Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression
about
Gene immunotherapy of chronic lymphocytic leukemia: a phase I study of intranodally injected adenovirus expressing a chimeric CD154 molecule.Nanocarrier-based immunotherapy in cancer management and research.Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regression.Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.
P2860
Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intratumoral delivery of CD154 ...... ersistence and gene expression
@ast
Intratumoral delivery of CD154 ...... ersistence and gene expression
@en
type
label
Intratumoral delivery of CD154 ...... ersistence and gene expression
@ast
Intratumoral delivery of CD154 ...... ersistence and gene expression
@en
prefLabel
Intratumoral delivery of CD154 ...... ersistence and gene expression
@ast
Intratumoral delivery of CD154 ...... ersistence and gene expression
@en
P2093
P2860
P356
P1433
P1476
Intratumoral delivery of CD154 ...... ersistence and gene expression
@en
P2093
J E Castro
J Melo-Cardenas
P2860
P2888
P304
P356
10.1038/CGT.2012.6
P577
2012-03-09T00:00:00Z
P6179
1050708693